Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Appointed director
Oxford Immunotec Global PLC (OXFD) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2022 SC 13G/A Alyeska Investment Group, L.P. reports a 0% stake in Oxford Immunotec Global PLC
02/14/2022 SC 13G/A Polar Capital Holdings Plc reports a 0% stake in Oxford Immunotec Global PLC
05/07/2021 SC 13G Grandeur Peak Global Advisors, LLC reports a 2.2% stake in Oxford Immunotec Global PLC
03/18/2021 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
03/12/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/12/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/08/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
03/08/2021 8-K Quarterly results
03/08/2021 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
03/02/2021 8-K/A Quarterly results
02/26/2021 8-K Quarterly results
02/17/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/17/2021 SC 13G/A Endurant Capital Management LP reports a 0% stake in Oxford Immunotec Global PLC
02/16/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/16/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/16/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/16/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2021 SC 13G Endurant Capital Management LP reports a 8.6% stake in Oxford Immunotec Global PLC
02/11/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2021 SC 13G Grandeur Peak Global Advisors, LLC reports a 2.2% stake in Oxford Immunotec Global PLC
02/10/2021 SC 13G/A First Light Asset Management, LLC reports a 0.4% stake in Oxford Immunotec Global PLC
02/08/2021 GN Oxford Immunotec Enters a Memorandum of Understanding (MOU) with GC MS (Green Cross Medical Science Corp. – South Korea) to Market the T-SPOT® Discovery SARS-CoV-2 Kit, for the Measurement of the T Cell Immune Response to SARS-CoV-2 Infection, in South Korea
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy